Diamyd Medical AB (publ) (FRA:DMN)
Germany
· Delayed Price · Currency is EUR 0.860
-0.005 (-0.58%)
Last updated: Dec 5, 2025, 8:03 AM CET
Diamyd Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 277.19 | 112.76 | 127.53 | 119.76 | 139.38 | Upgrade
|
| Short-Term Investments | - | 19.61 | - | 39.91 | - | Upgrade
|
| Cash & Short-Term Investments | 277.19 | 132.37 | 127.53 | 159.67 | 139.38 | Upgrade
|
| Cash Growth | 109.41% | 3.79% | -20.13% | 14.56% | 103.88% | Upgrade
|
| Accounts Receivable | - | 0.02 | 0.06 | 0.25 | 0.05 | Upgrade
|
| Other Receivables | 4.64 | 3.99 | 4.61 | 2.23 | 1.59 | Upgrade
|
| Receivables | 4.64 | 4.02 | 4.67 | 2.48 | 1.65 | Upgrade
|
| Prepaid Expenses | 10.58 | 22.76 | 8.61 | 10.86 | 21.95 | Upgrade
|
| Other Current Assets | - | - | - | 0 | - | Upgrade
|
| Total Current Assets | 292.4 | 159.14 | 140.81 | 173.01 | 162.97 | Upgrade
|
| Property, Plant & Equipment | 52.7 | 49.36 | 52.32 | 45.75 | 5.55 | Upgrade
|
| Long-Term Investments | 7.25 | 7.9 | 10.57 | 15.46 | 32.22 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.07 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.19 | 0.3 | 1.54 | 1.68 | - | Upgrade
|
| Other Long-Term Assets | 0.09 | 0.34 | 0.57 | 0.63 | 0.63 | Upgrade
|
| Total Assets | 352.64 | 217.04 | 205.81 | 236.52 | 201.44 | Upgrade
|
| Accounts Payable | 11.96 | 16.61 | 4.89 | 9.78 | 5.57 | Upgrade
|
| Accrued Expenses | 7.61 | 14.5 | 5.54 | 4.97 | 4.79 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.06 | - | Upgrade
|
| Other Current Liabilities | 7.92 | 8.92 | 9.43 | 6.56 | 1.04 | Upgrade
|
| Total Current Liabilities | 27.48 | 40.03 | 19.85 | 21.37 | 11.4 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.11 | 0.42 | 0.69 | 0.78 | 0.78 | Upgrade
|
| Other Long-Term Liabilities | 45.04 | 30.67 | 15.87 | 0 | 0 | Upgrade
|
| Total Liabilities | 72.64 | 71.12 | 36.41 | 22.15 | 12.18 | Upgrade
|
| Common Stock | 13.95 | 10.11 | 8.7 | 7.8 | 7.26 | Upgrade
|
| Additional Paid-In Capital | 884.67 | 586.55 | 460.29 | 390.51 | 248.9 | Upgrade
|
| Retained Earnings | - | - | -299.59 | -183.93 | -66.9 | Upgrade
|
| Comprehensive Income & Other | -618.61 | -450.74 | - | - | -0 | Upgrade
|
| Shareholders' Equity | 280 | 145.92 | 169.4 | 214.38 | 189.26 | Upgrade
|
| Total Liabilities & Equity | 352.64 | 217.04 | 205.81 | 236.52 | 201.44 | Upgrade
|
| Net Cash (Debt) | 277.19 | 132.37 | 127.53 | 159.67 | 139.38 | Upgrade
|
| Net Cash Growth | 109.41% | 3.79% | -20.13% | 14.56% | 103.88% | Upgrade
|
| Net Cash Per Share | 2.46 | 1.40 | 1.63 | 2.09 | 2.00 | Upgrade
|
| Filing Date Shares Outstanding | 137.5 | 104.09 | 85.78 | 76.93 | 71.57 | Upgrade
|
| Total Common Shares Outstanding | 137.5 | 99.72 | 85.78 | 76.93 | 71.57 | Upgrade
|
| Working Capital | 264.92 | 119.12 | 120.96 | 151.64 | 151.57 | Upgrade
|
| Book Value Per Share | 2.04 | 1.46 | 1.97 | 2.79 | 2.64 | Upgrade
|
| Tangible Book Value | 280 | 145.92 | 169.4 | 214.38 | 189.19 | Upgrade
|
| Tangible Book Value Per Share | 2.04 | 1.46 | 1.97 | 2.79 | 2.64 | Upgrade
|
| Land | - | - | - | 24.48 | - | Upgrade
|
| Buildings | 41.47 | 39.84 | 32.2 | - | - | Upgrade
|
| Machinery | 37.21 | 29.67 | 28.87 | 27.38 | 7.34 | Upgrade
|
| Construction In Progress | 0.99 | 0.41 | 0.83 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.